Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 12.00B | 11.02B | 9.87B | 8.93B | 7.57B | 6.21B | 4.16B | 3.05B | 2.49B | 1.70B | 1.03B | 580.4M | 1.21B | 1.53B | 1.41B | 143.4M | 101.9M | 175.5M |
| Gross Profit | 10.35B | 9.49B | 8.61B | 7.85B | 6.67B | 5.47B | 3.62B | 2.64B | 2.21B | 1.49B | 915.2M | 540.7M | 1.12B | 1.29B | 1.35B | 143.4M | — | — |
| Profitability | ||||||||||||||||||
| Operating Income | 4.17B | -232.9M | 3.83B | 4.31B | 2.78B | 2.86B | 1.20B | 635.1M | 123.2M | 9.9M | -466.9M | -692.4M | -610.0M | 46.7M | 113.8M | -696.1M | -614.0M | -462.7M |
| EBITDA | 4.38B | -25.7M | 4.01B | 4.46B | 2.91B | 2.97B | 1.30B | 707.6M | 184.6M | 71.3M | -404.5M | -629.2M | -561.6M | 84.9M | 148.9M | -665.6M | -583.9M | -430.5M |
| Net Income | 3.95B | -535.6M | 3.62B | 3.32B | 2.34B | 2.71B | 1.18B | 2.10B | 263.5M | -112.1M | -556.3M | -738.6M | -445.0M | -107.0M | 29.6M | -754.6M | -642.2M | — |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | $15.32 | $-2.08 | $13.89 | $12.82 | $9.01 | $10.29 | $4.51 | $8.09 | $1.04 | $-0.46 | $-2.31 | $-3.14 | $-1.98 | $-0.50 | $0.14 | $-3.77 | $-3.71 | $-3.27 |
| Shares Outstanding (dil.) | 258M | 258M | 261M | 259M | 260M | 263M | 261M | 259M | 253M | 245M | 241M | 235M | 225M | 215M | 209M | 200M | 173M | 141M |
Vertex Pharmaceuticals Inc. Income Statement — FAQ
Vertex Pharmaceuticals Inc. (VRTX) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's income statement history?
The chart and table above show Vertex Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.